SG11201808660UA - Amorphizing agent, amorphous composition comprising amorphizing agent and utilization thereof - Google Patents

Amorphizing agent, amorphous composition comprising amorphizing agent and utilization thereof

Info

Publication number
SG11201808660UA
SG11201808660UA SG11201808660UA SG11201808660UA SG11201808660UA SG 11201808660U A SG11201808660U A SG 11201808660UA SG 11201808660U A SG11201808660U A SG 11201808660UA SG 11201808660U A SG11201808660U A SG 11201808660UA SG 11201808660U A SG11201808660U A SG 11201808660UA
Authority
SG
Singapore
Prior art keywords
amorphizing agent
amorphizing
agent
utilization
amorphous composition
Prior art date
Application number
SG11201808660UA
Other languages
English (en)
Inventor
Takaaki Masuda
Kahori Fujii
Hirokazu Kobayashi
Original Assignee
Pola Pharma Inc
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Pharma Inc, Nihon Nohyaku Co Ltd filed Critical Pola Pharma Inc
Publication of SG11201808660UA publication Critical patent/SG11201808660UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
SG11201808660UA 2016-03-31 2017-03-28 Amorphizing agent, amorphous composition comprising amorphizing agent and utilization thereof SG11201808660UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016071569 2016-03-31
PCT/JP2017/012578 WO2017170509A1 (ja) 2016-03-31 2017-03-28 非晶質化剤、非晶質化剤を含んでなる非晶質の組成物及びその使用

Publications (1)

Publication Number Publication Date
SG11201808660UA true SG11201808660UA (en) 2018-11-29

Family

ID=59964539

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201808660UA SG11201808660UA (en) 2016-03-31 2017-03-28 Amorphizing agent, amorphous composition comprising amorphizing agent and utilization thereof

Country Status (8)

Country Link
JP (1) JP7021827B2 (ja)
KR (1) KR102359641B1 (ja)
CN (1) CN108883190B (ja)
AU (1) AU2017244688B2 (ja)
MY (1) MY197992A (ja)
PH (1) PH12018502095A1 (ja)
SG (1) SG11201808660UA (ja)
WO (1) WO2017170509A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017181387A (ja) * 2016-03-31 2017-10-05 株式会社ポーラファルマ 医薬組成物の形成する膜の評価方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3959205B2 (ja) 1999-08-04 2007-08-15 ポーラ化成工業株式会社 表面処理粉体及びそれを含有してなる皮膚外用剤
WO2003105841A1 (ja) 2002-06-18 2003-12-24 ポーラ化成工業株式会社 抗真菌医薬組成物
JP2006312598A (ja) 2005-05-09 2006-11-16 Pola Chem Ind Inc 医薬用の組成物
WO2007102241A1 (ja) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. 外用の医薬組成物
RU2415669C2 (ru) * 2006-03-08 2011-04-10 Нихон Нохияку Ко., Лтд. Фармацевтическая композиция для наружного применения
JP4999412B2 (ja) 2006-09-20 2012-08-15 ポーラ化成工業株式会社 微粒子粉体及びその製造方法
JP5345937B2 (ja) * 2007-09-05 2013-11-20 株式会社ポーラファルマ 抗真菌組成物
EP2416757A2 (en) * 2009-04-09 2012-02-15 Pola Pharma Inc. Antimycotic pharmaceutical composition
EP2744481A4 (en) * 2011-08-16 2015-07-01 Merck Sharp & Dohme USE OF INORGANIC MATRIX AND COMBINATIONS OF ORGANIC POLYMERS FOR THE PREPARATION OF STABLE AMORPHOUS DISPERSIONS
JP5662495B2 (ja) * 2013-02-08 2015-01-28 株式会社ポーラファルマ 可溶化剤形の医薬組成物
JP6503626B2 (ja) * 2013-03-28 2019-04-24 大正製薬株式会社 医薬組成物
JP5587488B1 (ja) * 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質

Also Published As

Publication number Publication date
JP2017186317A (ja) 2017-10-12
JP7021827B2 (ja) 2022-02-17
PH12018502095A1 (en) 2019-07-15
CN108883190B (zh) 2022-07-01
CN108883190A (zh) 2018-11-23
WO2017170509A1 (ja) 2017-10-05
AU2017244688A1 (en) 2018-11-22
AU2017244688B2 (en) 2022-11-10
KR102359641B1 (ko) 2022-02-08
KR20180126058A (ko) 2018-11-26
MY197992A (en) 2023-07-25

Similar Documents

Publication Publication Date Title
MX2017016363A (es) Fenoxifenilamidinas sustituidas con halogeno y el uso de estas como fungicidas.
WO2018195397A3 (en) Indole ahr inhibitors and uses thereof
WO2019126253A8 (en) Aryl and heteroaryl substituted indole compounds
MX2020005873A (es) Compuestos de 6-azaindol.
MX2018005292A (es) Inhibidores de acc y usos de los mismos.
SG11201804121RA (en) Novel biphenyl compound or salt thereof
MX2020006168A (es) Compuestos de 4-azaindol.
MX2018006288A (es) Inhibidores de acc tipo ester y usos de los mismos.
MX2018000050A (es) Fenoxihalogenofenilamidinas y su uso como fungicidas.
MX2020006014A (es) Compuestos de diazaindol.
WO2014144545A3 (en) Substituted benzoxazoles and methods of use thereof
UA124329C2 (uk) Піримідинілоксибензольні похідні як гербіциди
MX2019014104A (es) Compuesto novedoso de bifenilo o sal del mismo.
MX2022010755A (es) Inhibidores de quinasa y usos de los mismos.
NZ719968A (en) Pesticidal compositions and related methods
MY177933A (en) Herbicidal composition comprising quizalofop-p
WO2018160879A3 (en) Macromolecular corrosion (mcin) inhibitors: structures, methods of making and using the same
EA201990304A1 (ru) Способ контроля растений
MX2020006434A (es) Nuevos compuestos inhibidores del blanco mecanistico de rapamicina (mtor).
MX2018001517A (es) Derivados sustituidos de guanidina.
MX2015016332A (es) Inhibidores de alk biciclicos fusionados.
MX2017001064A (es) Piridonas como herbicidas.
MX2020006370A (es) Pirazolopiridina-diamidas, su uso como insecticida y procesos para prepararlas.
WO2017087917A3 (en) Bicarbonate biosensors, calcium biosensors, and uses thereof
MX2022005024A (es) Profarmacos de fosforo de estimuladores de guanilato ciclasa soluble (sgc).